Skip to content
Menu

Iridex Lowers FY2026 Sales Guidance from $51.000M-$53.000M to $46.000M-$48.000M vs $52.521M Est

Benzinga Newsdesk 13 hours ago

NewsGuidance

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Iridex (NASDAQ:IRIX) lowers FY2026 sales outlook from $51.000 million-$53.000 million to $46.000 million-$48.000 million vs $52.521 million estimate.

Iridex (NASDAQ:IRIX) lowers FY2026 sales outlook from $51.000 million-$53.000 million to $46.000 million-$48.000 million vs $52.521 million estimate.

Read at benzinga.com